EC Number   |
Title |
Organism |
|---|
    2.8.2.33 | A unique nonreducing terminal modification of chondroitin sulfate by N-acetylgalactosamine 4-sulfate 6-o-sulfotransferase |
Homo sapiens |
| 2.8.2.33 | Antibody GD3G7 selected against embryonic glycosaminoglycans defines chondroitin sulfate-E domains highly up-regulated in ovarian cancer and involved in vascular endothelial growth factor binding |
Homo sapiens |
| 2.8.2.33 | Difference between N-acetylgalactosamine 4-sulfate 6-O-sulfotransferases from human serum and squid cartilage in specificity toward the terminal and interior portion of chondroitin sulfate |
Homo sapiens |
| 2.8.2.33 | Enzymatic synthesis of chondroitin sulfate E by N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase purified from squid cartilage |
Todarodes pacificus |
| 2.8.2.33 | Expression of N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase involved in chondroitin sulfate synthesis is responsible for pulmonary metastasis |
Mus musculus |
| 2.8.2.33 | Expression of sulfotransferases involved in the biosynthesis of chondroitin sulfate E in the bone marrow derived mast cells |
Mus musculus |
| 2.8.2.33 | Galactomutarotase and other galactose-related genes are rapidly induced by retinoic acid in human myeloid cells |
Homo sapiens |
| 2.8.2.33 | Human N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase cDNA is related to human B cell recombination activating gene-associated gene |
Homo sapiens |
| 2.8.2.33 | Inhibition of N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase by -D-4-O-sulfo-N-acetylgalactosaminides bearing various hydrophobic aglycons |
Homo sapiens |
| 2.8.2.33 | Mast cell differentiation and activation is closely linked to expression of genes coding for the serglycin proteoglycan core protein and a distinct set of chondroitin sulfate and heparin sulfotransferases |
Mus musculus |
